Sun, May 19, 2013, 11:58 PM EDT - U.S. Markets closed
Amarantus Bioscience - AMBS.
Currently trading at .08.
Company's pateneted MANF technology could be worth billions long term.
Due diligence before a "big pharma" buyout or partnership is announced.
Best opportunity in the market currently trading at under a dime.
Read the recent Yahoo news.
Take the time to check it out.
Tremendous upside as a potential takeover target.